Intermittent Fasting: Efficacy, Safety, and Its Impact on Body Weight, Glucose Metabolism, and Gut Microbiota

Intermittent fasting (IF) has gained significant attention as a nutritional strategy with potential health-promoting effects. It typically involves periodic restriction of calorie intake or limiting the daily eating window. Growing scientific interest has led to a wide range of clinical and observational research exploring its biological and metabolic impacts. Existing studies suggest that IF may positively influence metabolic health, weight management, and cellular processes. However, the breadth of findings varies, and questions remain regarding its long-term safety and effectiveness across diverse populations, especially individuals with chronic conditions. A comprehensive evaluation of the current evidence is therefore warranted. An analysis of 55 publications, including clinical trials, observational studies, and review articles, was conducted. These sources were examined to assess the effects of various forms of IF on metabolic health, diabetes-related outcomes, gut microbiome composition, and broader physiological functions. Across most studies, IF was associated with moderate but clinically meaningful weight loss, enhanced insulin sensitivity, reductions in blood pressure, and improvements in lipid profiles. Some evidence also pointed to beneficial changes in gut microbiota, decreased oxidative stress, and increased autophagy activity. Comparisons with traditional caloric restriction indicate similar levels of effectiveness and safety, with IF potentially offering better adherence for certain individuals. Despite these promising outcomes, the current evidence base lacks long-term studies and comprehensive evaluations in specific clinical populations, limiting conclusions about sustained benefits and generalizability. IF appears to be a promising approach for the prevention and management of obesity and metabolic disorders. Its combination of physiological benefits and relative ease of implementation makes it an appealing strategy. Nonetheless, further long-term and population-specific research is needed to fully establish its safety, durability, and applicability across diverse groups.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-11-25
DOI
https://doi.org/10.7759/cureus.97773
Primary Topic
Dietary Effects on Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Intermittent Fasting: Efficacy, Safety, and Its Impact on Body Weight, Glucose Metabolism, and Gut Microbiota

Małgorzata Kubicka, Julia Żerdka, Patryk Brasse, Karolina Staszkiewicz et al.
Cureus
Dietary Effects on Health
article

Intermittent Fasting: Efficacy, Safety, and Its Impact on Body Weight, Glucose Metabolism, and Gut Microbiota

Małgorzata Kubicka, Julia Żerdka, Patryk Brasse, Karolina Staszkiewicz, Filip Czarnecki, Kacper K Staszkiewicz, Eliza Kwapień, Mateusz Piszka, Jakub Bartkowski
article en

Abstract

Intermittent fasting (IF) has gained significant attention as a nutritional strategy with potential health-promoting effects. It typically involves periodic restriction of calorie intake or limiting the daily eating window. Growing scientific interest has led to a wide range of clinical and observational research exploring its biological and metabolic impacts. Existing studies suggest that IF may positively influence metabolic health, weight management, and cellular processes. However, the breadth of findings varies, and questions remain regarding its long-term safety and effectiveness across diverse populations, especially individuals with chronic conditions. A comprehensive evaluation of the current evidence is therefore warranted. An analysis of 55 publications, including clinical trials, observational studies, and review articles, was conducted. These sources were examined to assess the effects of various forms of IF on metabolic health, diabetes-related outcomes, gut microbiome composition, and broader physiological functions. Across most studies, IF was associated with moderate but clinically meaningful weight loss, enhanced insulin sensitivity, reductions in blood pressure, and improvements in lipid profiles. Some evidence also pointed to beneficial changes in gut microbiota, decreased oxidative stress, and increased autophagy activity. Comparisons with traditional caloric restriction indicate similar levels of effectiveness and safety, with IF potentially offering better adherence for certain individuals. Despite these promising outcomes, the current evidence base lacks long-term studies and comprehensive evaluations in specific clinical populations, limiting conclusions about sustained benefits and generalizability. IF appears to be a promising approach for the prevention and management of obesity and metabolic disorders. Its combination of physiological benefits and relative ease of implementation makes it an appealing strategy. Nonetheless, further long-term and population-specific research is needed to fully establish its safety, durability, and applicability across diverse groups.

CureusVol. 17(11)
Wojewódzki Szpital Specjalistyczny nr 5 im. św. Barbary w Sosnowcu (PL), Polish Wood Cluster (PL), Alta (Poland) (PL), Szpital Kliniczny Nr 1 we Wrocławiu (PL)
Openalex Percentile: Top 54%
Dietary Effects on Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.